Prospective Evaluation of the Prevalence of Factor V Leiden Mutation in Portal or Hepatic Vein Thrombosis

Thromb Haemost 1997; 78(04): 1297-1298
DOI: 10.1055/s-0038-1657733

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Marie-Hélène Denninger

¹Hôpital Beaujon, Service d’Hématologie et Immunologie, Clichy, France
Dominique Helley

²Hôpital Bichat, Service d’Hématologie Biologique, Paris, France
Dominique Valla

³Hôpital Beaujon, Service d’Hepatologie, Clichy, France
Marie-Claude Guillin

¹Hôpital Beaujon, Service d’Hématologie et Immunologie, Clichy, France

References
1 Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-bizzacchi JM. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 1997; 77: 258-261
2 Sas G, Blasko G, Petro I, Griffin JH. A protein S deficient family with portal vein thrombosis. Thromb Haemost 1985; 54: 724
3 Foulc P, Le Bihan G, Guillerm C, Dorval I, Lellouche F. Thrombose portale chez une malade ayant une maladie de Vaquez et le facteur V Leiden. Press Med 1996; 25: 1126
4 Denninger MH, Beldjord K, Durand F, Denie C, Valla D, Guillin MC. Budd-Chiari syndrome and factor V Leiden mutation. Lancet 1995; 345: 525-526
5 Mambrini P, Mallet D, O’Callaghan T, Sebahoun G, Salducci J, Grimaud JC. Budd-Chiari syndrome and activated protein C resistance. J Hepat 1996; 24: 246-248
6 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
7 Cesarman G, Rosillo C, Jimenez G. Low incidence of activated protein C resistance genotype in patients with “idiopathic” hepatic and splanchnic vein thrombosis. Blood. 1995. 86. suppl. 1 1 to N° 10,3647 (Abst.)